IDH1 and glioblastoma: Among the 450 primary treatment-naïve conventional IDH-wildtype glioblastomas lacking somatic hypermutation, two tumors (2/450, < 1%) contained heterozygous inactivating mutations in a canonical mismatch repair gene affecting one of two alleles (Supplementary Fig. S3).